Effective shunt closure for pulmonary hypertension and liver dysfunction in congenital portosystemic venous shunt
Pediatric Pulmonology Jan 27, 2018
Uike K, et al. - Here, authors examined the clinical features and established the optimal management of congenital portosystemic venous shunt (CPSVS) with or without pulmonary arterial hypertension (PAH). PAH was successfully controlled by CPSVS closure with PAH-specific therapy. The occurrence and progression of PAH with CPSVS could be prevented with early CPSVS closure.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
